Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer

NCT00319618 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Gefitinib
DRUG: Docetaxel

Sponsor

AstraZeneca